Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid LeukemiaShanshan Pei, Craig T. Jordan, Ryan M. Sheridan et al.|Cancer Discovery|2020Cited by 550
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L. Jones, Craig T. Jordan, Brett M. Stevens et al.|Cell stem cell|2020Cited by 228
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia CellsHaobin Ye, Craig T. Jordan, Biniam Adane et al.|Cancer Cell|2018Cited by 113
Targeting MDS Stem Cells with Omacetaxine and Azacitidine for Newly Diagnosed High Grade Patients: Phase 1 Trial Results and Preliminary Mechanistic StudiesBrett M. Stevens, Daniel A. Pollyea, Amanda Winters et al.|Blood|2021Cited by 0